rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Natco Pharma Ltd.

524816 NATCOPHARM Group (A)

16 Oct,13:33
1398.05
7.30 (0.52%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Natco Pharma Ltd.

BUYSELL
28,895 1,390.75 1,411.00 - 1,381.10 1,638.35 - 725.00 25,039.08
NSE | BSE

Natco Pharma Ltd.

NATCOPHARM

16 Oct,13:33
1397.90
8.50 (0.61%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Natco Pharma Ltd.

BUYSELL
330,383 1389.4 1,411.85 - 1,386.10 1,639.00 - 724.20 4,633.69

News for Natco Pharma Ltd.

Mylan Settles...
Mylan Settles Patent Suit with Novo Nordisk over Generic Ozempic
Mylan Pharmaceuticals Inc. and Novo Nordisk have reached a settlement in the US over a patent infringement lawsuit regarding generic Ozempic, a drug used for blood sugar and weight loss.
Oct 07, 2024 10:46
Natco Pharma...
Natco Pharma Invests USD 8 Million in eGenesis for Xenotransplantation
Natco Pharma's Canadian arm invests USD 8 million in eGenesis, a biotech company focused on developing human-compatible organs for transplant. The investment will support research and bring...
Sep 04, 2024 15:44
Natco Pharma...
Natco Pharma Files Generic Cancer Drug Application with USFDA - Business News
Natco Pharma has submitted an ANDA to the USFDA for a generic version of Novartis' Tabrecta, a cancer drug. The company expects to be eligible for 180 days of marketing exclusivity.
Aug 29, 2024 17:10
Natco Pharma Q1 Profit Jumps 59% to Rs 668 Cr
Natco Pharma's consolidated net profit surged 59% to Rs 668 crore in Q1 FY24, driven by strong revenue growth. The company also declared an interim dividend of Rs 3 per share.
Aug 12, 2024 17:29
Akums Drugs Shares Debut at 7% Premium - IPO Success
Akums Drugs shares listed on BSE and NSE with a 7% premium over the issue price, drawing strong investor interest. The IPO was oversubscribed 63 times.
Aug 06, 2024 10:45

More News for Natco Pharma Ltd. »

(Rs. Crore)

Financial Results of Natco Pharma Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales3,568.902,351.001,767.801,653.501,790.20
Operating profit1,637.00844.70213.00417.60578.00
Interest14.508.6013.3011.3020.60
Gross profit1,727.20921.60294.30507.40681.20
EPS (Rs)72.9934.917.6216.9626.07

See more in Research Center »

Statements:Balance Sheet  |  P&L  |  Cash Flow
More:Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

About Natco Pharma Ltd.

Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations active pharmaceutical ingredients and Agro chemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs. The company specialises in producing complex medicines at affordable prices. NATCO is a science driven company and focuses on limited competition molecules in the US. Wikipedia

News for Pharmaceuticals and health care

Waaree Energies...
Waaree Energies IPO: Rs 4,321-cr Issue Opens Oct 21
Waaree Energies'' IPO to open on October 21, 2023 with a price band of Rs 1,427-1,503 per share. The solar panel maker aims to raise Rs 4,321 crore through the issue.
Oct 16, 2024 13:36
South Indian Bank...
South Indian Bank Q2 Profit Up 18% to Rs 325 Cr - Business News
South Indian Bank reported an 18% increase in Q2 profit to Rs 325 crore, driven by higher income and reduced NPAs. Learn more about the bank's financial performance.
Oct 16, 2024 12:51
Wockhardt Seeks...
Wockhardt Seeks Approval for Diabetes Drug Aspart Injection
Wockhardt has filed for marketing approval of its fast-acting insulin analog, Aspart injection, with the DCGI in India. This move aims to address the growing diabetes epidemic and provide patients...
Oct 16, 2024 11:38
6G Inclusivity:...
6G Inclusivity: Scindia Calls for Affordable, Accessible Standards
India's Communications Minister Jyotiraditya Scindia emphasizes the need for inclusive and affordable 6G standards at the India Mobile Congress (IMC).
Oct 16, 2024 11:19
India's Export...
India's Export Competitiveness: Goyal Emphasizes Quality over Subsidies
Commerce Minister Piyush Goyal urges Indian industry to prioritize quality over government subsidies for export competitiveness, highlighting the importance of Quality Control Orders (QCOs) and...
Oct 16, 2024 11:12

More News »

Top News

Waaree Energies...
Waaree Energies IPO: Rs 4,321-cr Issue Opens Oct 21
Waaree Energies'' IPO to open on October 21, 2023 with a price band of Rs 1,427-1,503 per share. The solar panel maker aims to raise Rs 4,321 crore through the issue.
Oct 16, 2024 13:36
TRAI to Consider...
TRAI to Consider All Inputs on Satcom Spectrum Allocation
TRAI Chairman Anil Kumar Lahoti says the regulator will consider all inputs before making a decision on satellite spectrum allocation. This comes as Starlink, Reliance Jio, and Bharti Airtel are...
Oct 16, 2024 13:23
Cottonseed Oil...
Cottonseed Oil Cake Futures Surge on Demand
Cottonseed oil cake futures prices rose on Wednesday due to increased demand for cattle feed, driving speculators to create fresh positions.
Oct 16, 2024 13:19
Copper Futures Rise on Higher Spot Demand
Copper prices surged in India's futures market on Wednesday, driven by increased spot demand. The rise was attributed to traders raising bets on higher prices.
Oct 16, 2024 13:19
Guar Seed Futures Rise on Spot Demand - PTI
Guar seed futures prices on Wednesday rose by Rs 20 to Rs 5,556 per quintal in futures trade due to speculators and a firm trend in the spot market.
Oct 16, 2024 13:18

More Top News »

Report Card

PE Ratios
19.05
EPS (Rs.)
72.99
Sales (Rs. Cr)
1,236.90
Face Value (Rs.)
2
Net Profit Margin (%)
36.61
Last Bonus
Last Dividend(%)
150
Return on Average Equity
23.36

BSE Announcements from Natco Pharma Ltd. (See all)

announcement Announcement under Regulation 30 (LODR)-Change in Management - 5 day(s) ago
announcement Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 - 07 Oct 2024

Compare 'Natco Pharma Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,909.55
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,664.65
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,062.30
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 7,092.70
  • Compare
  • Max Healthcare Institute Ltd.
  • 947.45
  • Compare
  • Divi's Laboratories Ltd.
  • 6,212.85
  • Compare
  • Alkem Laboratories Ltd.
  • 6,247.25
  • Compare

Mutual Funds Invested

Most Active

  • Change (Rs.)
  •  

REDIFFGURUS

I am 51 years old. I can invest 1 lakh per month. I...

I have sold a residential property in March 2023 and...

Sir,Assessess own commercial property rentals income...

I have purchased a residential flat in december 2021...

Sir,Thank you for answering my earlier query in...

Sir my age is 44. If I have to do SIP of 5000 per...

More REDIFFGURUS

RediffGurus

Money question

I have taken early retirement due to my health...

Natco Pharma Ltd. performance snapshot

If you had invested Rs.  in Natco Pharma Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio
Natco Pharma Ltd.
Share Price » Fundamentals » Financial » Technicals » Screener » Open Demat »

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume

ALL MONEYWIZ PAGES

rediff on the net© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
Close
Add Natco Pharma Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Natco Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close